Changes in HIV Prevalence and Risk Among New Injecting Drug Users in a Russian City of High HIV Prevalence

Platt, Lucy; Rhodes, Tim; Hickman, Matthew; Mikhailova, Larissa; Lisetsky, Konstantin; Sarang, Anya; Lewis, Kim; Parry, John

doi:10.1097/qai.0b013e318165dbf7

Cited by 19 publications

(14 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In Estonia and Lithuania, an estimated 58–70% of PWID had been in prison at least once 74. In Georgia and Russia, this figure was between 6% and 37%,18 52 64 65 79 121 122 In Central Europe, between 18% and 50% of respondents report previously having been in prison 93 107…”

Section: Resultsmentioning

confidence: 99%

“…No studies examined risk factors linked to HIV in the Centre, and so we summarise the findings of the multivariate HIV risk factor analyses from 14 papers identified by our review in the East,49 51–53 57 65 72 73 88 113 121 123–125 although two65 72 present new analyses of data already published in other papers also presented here 123 125 Table 1. summarises the key characteristics of the 14 papers as well as the factors explored in the multivariate analysis.…”

Section: Resultsmentioning

confidence: 99%

“…Several studies have examined contact with law enforcement agencies as an environmental factor linked with the odds of being HIV infected, although the results produced by the systematic review have large CIs and are largely inconclusive 52 65 113 125. The review reveals that contact between police and PWID in the region is highly commonplace and no studies examined the frequency or duration of contact.…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy

et al. 2012

Self Cite

View full text Add to dashboard Cite

Background and objectivesHIV among people who inject drugs (PWID) is a major public health concern in Eastern and Central Europe and Central Asia. HIV transmission in this group is growing and over 27 000 HIV cases were diagnosed among PWID in 2010 alone. The objective of this systematic review was to examine risk factors associated with HIV prevalence among PWID in Central and Eastern Europe and Central Asia and to describe the response to HIV in this population and the policy environments in which they live.DesignA systematic review of peer-reviewed and grey literature addressing HIV prevalence and risk factors for HIV prevalence among PWID and a synthesis of key resources describing the response to HIV in this population. We used a comprehensive search strategy across multiple electronic databases to collect original research papers addressing HIV prevalence and risk factors among PWID since 2005. We summarised the extent of key harm reduction interventions, and using a simple index of ‘enabling’ environment described the policy environments in which they are implemented.Studies reviewedOf the 5644 research papers identified from electronic databases and 40 documents collected from our grey literature search, 70 documents provided unique estimates of HIV and 14 provided multivariate risk factors for HIV among PWID.ResultsHIV prevalence varies widely, with generally low or medium (<5%) prevalence in Central Europe and high (>10%) prevalence in Eastern Europe. We found evidence for a number of structural factors associated with HIV including gender, socio-economic position and contact with law enforcement agencies.ConclusionsThe HIV epidemic among PWID in the region is varied, with the greatest burden generally in Eastern Europe. Data suggest that the current response to HIV among PWID is insufficient, and hindered by multiple environmental barriers including restricted access to services and unsupportive policy or social environments.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy

et al. 2012

Self Cite

View full text Add to dashboard Cite

show abstract

“…La cuarta parte de los UDIs de este estudio, se encuentran infectados por el VIH o VHC, en forma de infección única o de coinfección, cifras muy bajas a las encontradas en otros países (Platt et al, 2008;Ruan et al, 2007). No obstante, este colectivo presenta una alta prevalencia en comparación con la población general del país (Ministerio de Salud y Proteccion Social, 2012), vinculado no sólo al uso de drogas por vía inyectable, sino además a otras características y conductas de riesgo (Hagan et al, 2007).…”

Section: En Los úLtimos Seis Meses… Si Ic 95%unclassified

Hepatitis C y VIH en usuarios de drogas inyectables en Armenia-Colombia

Fernández¹,

Segura-Cardona²,

Montoya-Vélez³

et al. 2015

Adicciones

View full text Add to dashboard Cite

Hepatitis C y VIH en usuarios de drogas inyectables en Armenia-ColombiaHepatitis C and HIV in injecting drug users in Armenia, Colombia Dedsy Berbesi-Fernández, Ángela Segura-Cardona, Liliana Montoya-Vélez, Guillermo A. Castaño-Perez* *Docentes-Investigadores, Facultad de Medicina. Universidad CES Un aumento constante y progresivo en la disponibilidad de heroína en Colombia en las últimas décadas, y el uso de esta droga vía intravenosa, ha establecido la necesidad de prevenir una posible epidemia de VIH y hepatitis C. Esta investigación determino la seroprevalencia de hepatitis C y VIH según características sociodemográficas y comportamientos de riesgo en población que se inyecta drogas en Armenia-Colombia.Estudio transversal en 265 usuarios captados a través de muestreo guiado por el encuestado previo consentimiento informado. La seroprevalencia de hepatitis C fue 22,3% [IC95% 12,3%-23,5%]; la infección por VIH fue 2,6% [IC95% 0,4-6,0]. El 67,5% reportó inyección por más de dos años, el 35% compartió jeringas y agujas y el 12,4% utilizó condón en su última relación sexual. Los usuarios que no adquirían jeringas en droguerías en los últimos seis meses tienen 2,7[IC95% 1,32-5,48] veces el riesgo de hepatitis C; la frecuencia diaria de inyección fue mayor en los casos positivos con VIH [OR 2,87; IC95% 0,9] pero no significativa. La cuarta parte de los encuestados, están infectados por VIH o hepatitis C, en forma de infección única o coinfección. Este estudio identificó prácticas de riesgo, como compartir jeringas y baja utilización del condón en los últimos seis meses, factores de riesgo documentados y discutidos mundialmente. Esta investigación constituye un primer paso en la búsqueda de estrategias para prevenir la propagación de infecciones por VIH y hepatitis C en redes de usuarios de drogas inyectables.Palabras clave: hepatitis C, VIH, heroína, epidemiologia.Resumen adicciones vol. 27, nº 4 · 2015 original

show abstract

“…The same development is observed in the Baltic States and in Central Asian countries, although imported heroin was never widely available in Ukraine and domestic practice remains in urban and rural areas. Elsewhere, the production of home injectable continues along emerging heroin markets [10].…”

Section: From the Desomorphine To The Krokodilmentioning

confidence: 99%